The APIs enable surgical robotics and navigation partners to integrate VISIE’s spatial computing and real-time scanning capabilities into existing robotic platforms with minimal integration overhead.
The first patient is enrolled in a PMS Study of ELEOS with NanoCept Antibacterial Implant Technology, that offers a proactive approach against intraoperative bacterial contamination.
The study evaluated use of Regenative Labs' umbilical cord connective tissue allografts for supplementation in cases of posterior tibial tendon degeneration.